Changes are coming to our lives and world that may rival the industrial and internet revolutions. Jeremy Schwartz and Kara Marciscano discuss the BioRevolution already underway and identify the range of business sectors we believe are best positioned to benefit.
The more market valuations rise, the more important we believe it is to reconnect stock weights with their underlying earnings. Jeremy Schwartz provides potential solutions for investors seeking to reconnect their equity portfolios to stocks.
Following post-COVID-19 lows, there has been an uptick in the level of buybacks within the S&P 500. Against this backdrop, Kara Marciscano makes the case that investors should consider leaning into quality and shareholder yield in the back half of 2021.
Once fears of the delta variant subside and the recovery continues, we believe that small caps may continue as important pieces of the economic recovery. Until then, Brian Manby explains why investors should be wary of prevailing large-cap valuations in their portfolios.
The history of cap weighting may surprise investors. Jeff Weniger explains why WisdomTree chooses to weight by fundamentals.
After a decade of growth outperformance, value has taken over. For investors seeking value-like valuations with an investment process that favors quality, Jeremy Schwartz makes the case to consider our quality dividend growth Fund (DGRW).